___

• O’Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology. 2005;117:1–10.
• Deniz G, Erten G, Kucuksezer UC et al. Regulatory NK Cells Suppress Antigen-Specific T Cell Responses The Journal of Immunology. 2008;180: 850–7.
• Moretta L, Biassoni R, Bottino C et al. Human NK cells and their receptors. Microbes Infect 2002;4:1539-44.
• Warren HS, Campbell AJ, Waldron JC et al. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. Int Immunol. 2001;13:1043-52.
• Keaney L, Williams F, Meenagh A et al. Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3. Tissue Antigens. 2004;64:188-94.
• Williams F, Meenagh A, Sleator C et al. Investigation of killer cell immunoglobulin like receptor gene diversity: I. KIR2DL4. Hum Immunol. 2004;65:31-8.
• http://www.ebi.ac.uk/ipd/kir/introduction.html. erişim tarihi 29.06.2011
• André P, Biassoni R, Colonna M et al. New nomenclature for MHC receptors. Nat Immunol. 2001;2:661.
• Middleton D, Williams F, Halfpenny IA. KIR genes. Transplant Immunology. 2005; 14:135–42.
• Borrego F, Kabat J, Kim DK et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol. 2002;38:63760.
• Halfpenny IA, Middleton D, Barnett YA et al. Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum Immunol. 2004;65:602-12.
• Marsh SG, Parham P, Dupont B et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol. 2003;64:648-54.
• Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753-63.
• Khakoo SI, Rajalingam R, Shum BP et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity. 2000;12:687-98.
• Wilson MJ, Torkar M, Haude A et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A. 2000;97:4778-83.
• Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity. 2001;15:363-74.
• Middleton D, Gonzalez A, Gilmore PM. Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol. 2007;68:128-34.
• Denis L, Sivula J, Gourraud PA et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Re´ union Tissue Antigens. 2005;66:267–76.
• Shilling HG, Young N, Guethlein LA et al. Genetic control of human NK cell repertoire. J Immunol. 2002;169:239-47.
• Shilling HG, Guethlein LA, Cheng NW et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol. 2002;168:2307-15.
• Jacobs R, Stoll M, Stratmann G et al. CD16- CD56+ natural killer cells after bone marrow transplantation. Blood. 1992;79:3239-44.
• Witt CS, Dewing C, Sayer DC et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation. 1999;68:1784-89.
• Maxwell LD, Wallace A, Middleton D et al. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens. 2002;60:254-58.
• Hsu KC, Liu XR, Selvakumar A et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002;169:5118-29.
• Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002;54:221-9.
• Bishara A, Brautbar C, Eid A et al. Killer inhibitory receptor mismatching and liver transplantation outcome. Transplant Proc. 2001;33:2908.
• Carrington M, Norman P. The KIR Gene Cluster. U.S. Natl. Library Med., National Center for Biotechnology Information, Bethesda, MD; 2003.
• Vilches C, Rajalingam R, Uhrberg M et al. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol. 2000;164:5797-804.
• Gómez-Lozano N, Gardiner CM, Parham P et al. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics. 2002;54:314-19.
• Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol. 2000;165:6416-21.
• Norman PJ, Carrington CV, Byng M et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun. 2002;3:86-95.
• Watzl C, Peterson M, Long EO. Homogenous expression of killer cell immunoglobulin-like receptors (KIR) on polyclonal natural killer cells detected by a monoclonal antibody to KIR2D. Tissue Antigens. 2000;56:240-47.
• Moretta L, Moretta A. Killer immunoglobulin-like receptors Current Opinion in Immunology. 2004;16:626–33.
• Santaourlidis S, Trompeter HI, Weinhold S et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol. 2002;169:4253-61.
• Zambello R, Della Chiesa M, Trentin L et al. Expression and functional and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL). Blood. 2003;102:1797-805.
• Pando MJ, Gardiner CM, Gleimer M et al. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol. 2003;171:6640-49.
• Middleton D, Menchaca L, Rood H et al. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 2003;61:403-7.
• Ozturk OG, Polat G, Atik U. Diversity of killer cell immunoglobulin-like receptor genes in southern Turkey. Molec Biol Rep 2011 May 23 (in press)
• Velardi A, Ruggeri L, Alessandro et al. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 2002;23:438-44.
• Williams AP, Bateman AR, Khakoo SI. Hanging in the balance. KIR and their role in disease. Mol Interv. 2005;5:226-40.
• Nowakowski GS, Morice WG, Phyliky RL et al. Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol. 2005;128:490-92.
• Poszepczynska-Guigné E, Schiavon V, D'Incan M et al. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol. 2004;122:820-23.
• López-Vázquez A, Rodrigo L, Martínez-Borra J et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis. 2005;192:162-5.
• Naumova E, Mihaylova A, Stoitchkov K et al. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother. 2005;54:172-8.
• Norris S, Doherty DG, Curry M et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother. 2003;52:53-8.
• Ozturk OG, Gun FD, Polat G. Killer cell immunoglobulin-like receptor genes in patients with breast cancer. Med Oncol. 2011 Apr 9 (in press).